1 citations
,
March 1989 in “Proceedings of the British Society of Animal Production” This article reviews how photoperiod, melatonin, and prolactin influence moult timing in mammals, focusing on cashmere goats, but reports no new experimental findings.
May 2026 in “Quality in Sport” This study suggests that berberine may offer multiple benefits for women with polycystic ovary syndrome by improving metabolic and hormonal profiles, though further research is needed on its long-term effects on reproductive outcomes.
October 2025 in “World Journal of Biology Pharmacy and Health Sciences” This review highlights the role of sex hormones in skin health, observing that hormonal changes throughout a woman's life can affect skin conditions such as acne and hair loss, with treatments involving hormonal therapies and the importance of a multidisciplinary approach.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This source reviews the influence of sex hormones on skin health, detailing how hormonal fluctuations impact dermatological conditions throughout a woman's life and highlighting the necessity for integrated dermatological, gynecological, and endocrine care alongside mental health support to address these conditions' physical and psychological effects.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review describes how sex hormones like estrogens and androgens influence skin health, linking hormonal fluctuations to conditions such as acne and hair loss, and underscores the importance of a multidisciplinary approach to treatment that includes mental health support.
September 2022 in “Research Square (Research Square)” This study found that while pro-, pre-, and synbiotics may have beneficial effects on certain PCOS-related outcomes, the certainty of this evidence is low to very low.
November 2020 in “TURKDERM” This study reports that hormonal therapies, particularly combined oral contraceptives, are commonly used and effective in treating acne in women, especially those with hormonal imbalances or specific acne patterns, regardless of their serum androgen levels.
November 2008 in “Pediatrics in Review” This review summarizes recent developments in oral contraceptive pills and other contraceptive methods, highlighting advances in formulations and delivery systems to improve efficacy and user compliance.
March 2007 in “Journal of Obstetrics and Gynaecology Canada” This review discusses the diagnosis and treatment of hyperandrogenism in women, emphasizing that cyproterone acetate is effective for severe hirsutism, though it reports no new clinical findings.
December 1982 in “PubMed” This review discusses the use of different types of oral contraceptive pills and highlights their effectiveness, potential side effects, and contraindications without presenting new clinical data.
This article reviews pathologic mechanisms causing hair changes in women on hormonal contraceptives or pregnant and reports no new study results; hormonal effects on the hair cycle stages are suggested.
March 2023 in “Journal of Drugs in Dermatology” This paper reviews the role of various hormonal therapies in treating hidradenitis suppurativa and does not report new clinical results.
63 citations
,
January 2012 in “The European Journal of Contraception & Reproductive Health Care” This study concluded that combined hormonal contraceptives containing desogestrel, drospirenone, or cyproterone acetate were associated with a higher risk of venous thromboembolism compared to those containing levonorgestrel.
118 citations
,
September 2004 in “Clinics in Dermatology” This review discusses the role of hormones in acne vulgaris and highlights the need for further research on their mechanisms of action; it reports no new clinical results.
83 citations
,
December 2012 in “International journal of endocrinology and metabolism/International journal of endocrinology and metabolism.” This article reviews the diverse clinical applications of oral contraceptives beyond birth control, suggesting their effectiveness in treating various female health disorders and conditions.
46 citations
,
January 2007 in “The European Journal of Contraception & Reproductive Health Care” This review discusses the increased risk of venous thromboembolism associated with combined hormonal contraceptives, particularly noting higher risks with certain progestins like desogestrel, gestodene, and cyproterone acetate, but reports no new clinical findings.
4 citations
,
January 2025 in “International Journal of Yoga” This study found that regular yoga practice could benefit women with PCOS by improving hormonal balance, mitochondrial health, oxidative stress, and inflammation, while also reducing depression symptoms, suggesting yoga as a supportive therapy for managing PCOS.
August 2026 in “Cosmoderma” This review identifies sebaceous gland disorders as key indicators of hormonal imbalances, detailing how various hormones affect sebaceous function, and emphasizes a multidisciplinary approach to improve diagnosis and management by integrating endocrine, metabolic, and dermatologic insights.
38 citations
,
October 1996 in “Dermatologic Clinics” This review discusses inflammatory and medication-related skin conditions associated with kidney disease and emphasizes the importance of timely referral to nephrology, reporting no new clinical results.
3 citations
,
January 1985 in “PubMed” This review discusses the complex dermatological effects of oral contraceptives, including both hormonal benefits and potential toxicities, but reports no new clinical results.
October 2025 in “Česká gynekologie” This study conducted in fertility clinics in Abbottabad found that hyperprolactinemia is the most prevalent cause of secondary amenorrhea, affecting 31.7% of cases, followed by drug-induced amenorrhea in 14.3% of patients, with oral contraceptives and omeprazole as common factors.
June 2026 in “Brazilian Journal of Health Review” In this study, a qualitative review of research suggested that regular moderate physical activity and healthy lifestyle habits may help manage male androgenetic alopecia by improving metabolic and hormonal balance, although excessive exercise could worsen hormonal effects linked to the condition.
17 citations
,
January 2004 in “European journal of obstetrics, gynecology, and reproductive biology/European journal of obstetrics & gynecology and reproductive biology” This review discusses the use of ethinylestradiol combined with antiandrogenic progestin for treating androgenisation symptoms and improving metabolic and menstrual health in women, but it does not provide new clinical data.
11 citations
,
October 1986 in “International Journal of Gynecology & Obstetrics” This study found that the combination of ethinylestradiol and desogestrel significantly decreased hair growth and hormone levels in hirsute women, suggesting a relationship between hormone changes and treatment effectiveness.
April 2017 in “European Psychiatry” This study found that females treated with atypical anti-psychotics had a higher prevalence of probable polycystic ovarian syndrome compared to normal controls.
This study found a significant association between increased waist circumference and body mass index and female pattern hair loss in premenopausal women, suggesting the importance of screening for metabolic syndrome in these patients.
May 2019 in “Asian Journal of Pharmaceutical and Clinical Research” This study found a significant association between unhealthy food patterns and higher BMI in young women with PCOS, emphasizing the need for awareness of lifestyle's impact on hormonal and metabolic health.
9 citations
,
November 2008 in “Journal of Womens Health” This study found that recruiting healthy naturally menopausal women for a DHEA therapy trial was challenged by concerns about hormonal treatments and time constraints, impacting study feasibility.
3 citations
,
January 2015 in “Evidence-based Complementary and Alternative Medicine” This review discusses pumpkin seed oil as a potential treatment for androgenetic alopecia but reports no clinical results on its effects on frontal hair loss; it emphasizes the need for further research.
October 2023 in “Journal of Cosmetic Dermatology” In this study, a combination of 5% minoxidil lotion and 0.25% topical finasteride spray significantly increased hair density and improved photographic assessments in men with androgenetic alopecia compared to the treatments used alone, with all methods showing good tolerability.